Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $11000.0.

  • ImmunoTech's Other Working Capital Changes fell 9833.84% to $11000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year decrease of 23798.36%. This contributed to the annual value of -$576000.0 for FY2024, which is 21851.85% down from last year.
  • ImmunoTech's Other Working Capital Changes amounted to $11000.0 in Q3 2025, which was down 9833.84% from -$394000.0 recorded in Q2 2025.
  • ImmunoTech's 5-year Other Working Capital Changes high stood at $678000.0 for Q4 2023, and its period low was -$1.6 million during Q4 2024.
  • Over the past 3 years, ImmunoTech's median Other Working Capital Changes value was $11000.0 (recorded in 2025), while the average stood at -$76363.6.
  • Per our database at Business Quant, ImmunoTech's Other Working Capital Changes skyrocketed by 38658.01% in 2024 and then plummeted by 69193.55% in 2025.
  • ImmunoTech's Other Working Capital Changes (Quarter) stood at $678000.0 in 2023, then tumbled by 336.58% to -$1.6 million in 2024, then skyrocketed by 100.69% to $11000.0 in 2025.
  • Its Other Working Capital Changes was $11000.0 in Q3 2025, compared to -$394000.0 in Q2 2025 and -$367000.0 in Q1 2025.